2023
DOI: 10.3390/ijms241713065
|View full text |Cite
|
Sign up to set email alerts
|

Research Progress of Pyroptosis in Fatty Liver Disease

Rongxuan Li,
Weiyue Xue,
Huiting Wei
et al.

Abstract: Fatty liver disease (FLD) is a clinical and pathological syndrome characterized by excessive fat deposition and even steatosis in hepatocytes. It has been proven that liver inflammation induced by fat and its derivatives are involved in the pathogenesis of FLD, while the precise mechanism still remains poorly understood. Pyroptosis is programmed inflammatory cell death driving cell swelling and membrane rupture. Pyroptosis is initiated by the activation of inflammasomes and caspases, which further cleaves and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 99 publications
(145 reference statements)
0
0
0
Order By: Relevance
“…Figure 5 shows the scheme of hepatocyte protection from ferroptosis due to MSC and MSC derivatives. Recent studies have shown that inflammasome-mediated pyroptosis is a driver of inflammation and plays a critical role in the progression of liver pathologies, such as autoimmune liver diseases [238], liver fibrosis [239], and fatty liver diseases [240,241]. Therefore, pharmacological pyroptosis targeting may become an option for reducing inflammation in liver diseases.…”
Section: Anti-ferroptosis and Anti-pyroptosis Effects Of Mscmentioning
confidence: 99%
“…Figure 5 shows the scheme of hepatocyte protection from ferroptosis due to MSC and MSC derivatives. Recent studies have shown that inflammasome-mediated pyroptosis is a driver of inflammation and plays a critical role in the progression of liver pathologies, such as autoimmune liver diseases [238], liver fibrosis [239], and fatty liver diseases [240,241]. Therefore, pharmacological pyroptosis targeting may become an option for reducing inflammation in liver diseases.…”
Section: Anti-ferroptosis and Anti-pyroptosis Effects Of Mscmentioning
confidence: 99%
“…Likewise, cleavage at D36 of pro-IL-18 generates an 18 kDa mature protein from its 23 kDa pro-form, which possesses enhanced inflammatory property. The aftermath of caspase-1 cleavage is not just the maturation of IL-1 cytokines but also cleavage of gasdermin D [14]. Cleavage of gasdermin D results in translocation of its N-terminal fraction into the plasma membrane to cause pore formation.…”
Section: Introductionmentioning
confidence: 99%
“…Current research indicates that the pathogenesis of NAFLD is complex, with steatosis, lipotoxicity, and inflammatory responses playing critical roles ( Cobbina and Akhlaghi, 2017 ). Recent studies have underscored the importance of pyroptosis, a specific type of cell death, as a pivotal element in modulating inflammation and immune responses ( Yu et al, 2021 ; Li et al, 2023 ). Feng et al 2022) observed that upregulation of phosphorylated STAT3 promotes Anxa2 expression at the transcriptional level, thereby activating caspase-1-mediated hepatocyte pyroptosis and fibrosis in NASH.…”
Section: Introductionmentioning
confidence: 99%